Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elena Ricciardi"'
Autor:
Elena Giordani, Matteo Allegretti, Alberto Sinibaldi, Francesco Michelotti, Gianluigi Ferretti, Elena Ricciardi, Giovanna Ziccheddu, Fabio Valenti, Simona Di Martino, Cristiana Ercolani, Diana Giannarelli, Grazia Arpino, Stefania Gori, Claudia Omarini, Alberto Zambelli, Emilio Bria, Ida Paris, Simonetta Buglioni, Patrizio Giacomini, Alessandra Fabi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-11 (2024)
Abstract Background During targeted treatment, HER2-positive breast cancers invariably lose HER2 DNA amplification. In contrast, and interestingly, HER2 proteins may be either lost or gained. To longitudinally and systematically appreciate complex/di
Externí odkaz:
https://doaj.org/article/92bb4cafdd7145c5a75ef4fcaf8a3e78
Autor:
Simone Fortunati, Chiara Giliberti, Marco Giannetto, Alessandro Bertucci, Sabrina Capodaglio, Elena Ricciardi, Patrizio Giacomini, Valentina Bianchi, Andrea Boni, Ilaria De Munari, Roberto Corradini, Maria Careri
Publikováno v:
Biosensors and Bioelectronics: X, Vol 15, Iss , Pp 100404- (2023)
Liquid biopsy is a non-invasive and efficient technique for the detection of tumor biomarkers in biological fluids, which currently represents a new frontier in theranostics and precision medicine. Among mutations of the KRAS oncogene, p.G12D single
Externí odkaz:
https://doaj.org/article/23305f6eed1d44ebb5bfe7f1fb3282f1
Autor:
Elena Ricciardi, Elena Giordani, Giovanna Ziccheddu, Italia Falcone, Patrizio Giacomini, Maurizio Fanciulli, Michelangelo Russillo, Marianna Cerro, Gennaro Ciliberto, Aldo Morrone, Antonino Guerrisi, Fabio Valenti
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 4014 (2023)
Precision medicine has driven a major change in the treatment of many forms of cancer. The discovery that each patient is different and each tumor mass has its own characteristics has shifted the focus of basic and clinical research to the singular i
Externí odkaz:
https://doaj.org/article/7b560fb53838429cbbee2051f2614bea
Autor:
Elena Giordani, Antonella Palazzo, Angelo Minucci, Francesco Pavese, Ida Paris, Elisa De Paolis, Elena Ricciardi, Armando Orlandi, Sergio Pannunzio, Giordana Tiberi, Luisa Carbognin, Emilio Bria, Diana Giannarelli, Giovanni Scambia, Patrizio Giacomini, Alessandra Fabi
Publikováno v:
Journal of Clinical Oncology. 40:1046-1046
1046 Background: Trastuzumab Deruxtecan (TDXd), a novel antibody-drug conjugate (ADC) that combines trastuzumab with a topoisomerase I inhibitor, has recently demonstrated high efficacy in HER2-overexpressing breast cancer after trastuzumab failure.
Lower limb amputation (LLA) is the drastic stage of peripheral arterial disease (PAD) where the hyperhomocysteinemia (H-HCY) seems to be a risk factor. Surprisingly, in literature the levels and the role of homocysteinemia (HCY) in persons with LLA a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a78eeac64fbf132c1ee41bdbfd1eddd
http://hdl.handle.net/11573/1478173
http://hdl.handle.net/11573/1478173
Autor:
Domenico Prisco, Antonella Scalera, Elena Ricciardi, Alessandro Di Minno, Gaia Spadarella, Giovanni Di Minno
Publikováno v:
Blood reviews. 29(5)
Gastrointestinal bleeding (GIB) is a potentially fatal and avoidable medical condition that poses a burden on global health care costs. Current understanding of the roles of platelet activation and thrombin generation/activity in vascular medicine ha
Publikováno v:
Internal and Emergency Medicine. 10:533-534
The anticoagulant effect of Dabigatran etexilate, Rivaroxaban, and Apixaban is dose-predictable, steady, and little influenced by diet and drugs [1]. Thus, similar to lowmolecular weight heparin, laboratory tests have been unnecessary to evaluate suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1a977cfa91a309c31b67c3b0c28927
http://hdl.handle.net/11588/597287
http://hdl.handle.net/11588/597287